Echo Therapeutics, Inc. — Form D

Echo Therapeutics, Inc. of Iselin, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2011-02-15. The offering totals $3.5M, of which $3.5M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Vincent D EnrightDirectorRye, NY
WILLIAM F GRIECODirectorFRANKLIN, MA
Patrick T MooneyDirectorHaddonfield, NJ
Shawn K SinghDirectorSouth San Francisco, CA
James F SmithDirectorBellevue, NE
HARRY G MITCHELLExecutive OfficerFRANKLIN, MA
Patrick T MooneyExecutive OfficerHaddonfield, NJ
Robert LangerDirectorPittsburgh, PA
William GriecoDirectorAustin, TX
James SmithDirectorParker, CO
Patrick MooneyDirectorHaddonfield, NJ
Patrick MooneyExecutive OfficerHaddonfield, NJ
Shawn SinghDirectorHouston, TX
Walter WitoshkinDirectorSan Francisco, CA
Scott W HollanderDirectorIselin, NJ
Scott W HollanderExecutive OfficerIselin, NJ
Alan W SchoenbartExecutive OfficerIselin, NJ
Michael M GoldbergDirectorIselin, NJ
Shepard M GoldbergDirectorIselin, NJ
Christopher SchnittkerExecutive OfficerCarneys Point, NJ
Robert DomanDirectorPhiladelphia, PA
Robert DomanExecutive OfficerPhiladelphia, PA
Kimberly BurkeExecutive OfficerPhiladelphia, PA
Vincent EnrightDirectorPhiladelphia, PA
HARRY MITCHELLExecutive OfficerFRANKLIN, MA

Other filings by this issuer (8)

FiledFormOfferingSold
2016-02-08D$6.0M$1.8M
2013-12-19D$10.0M$10.0M
2011-02-15D/A$3.0M$2.9M
2010-11-05D$3.0M
2010-10-21D$5.0M$2.5M
2009-12-07D$563K$563K
2009-11-20D$3.6M$3.0M
2009-07-28D$2.0M$2.0M

More